Skip to main content
. Author manuscript; available in PMC: 2021 Sep 17.
Published in final edited form as: Cancer Treat Res Commun. 2020 Sep 17;25:100210. doi: 10.1016/j.ctarc.2020.100210

Fig. 1. Synthetic scheme for conversion of MGN to Mito-MGN and Mito-MGN4.

Fig. 1.

Mito-MGN refers to Mito-MGN10, containing a 10-carbon alkyl linker. The following reagents and conditions were used: i, 10-bromodecyltriphenylphosphonium bromide, DMF, K2CO3, 35 °C, 24 h, 35%. ii, 4-bromobutyltriphenylphosphonium bromide, K2CO3, DMF, 35 °C, 24 h, 41%.